Respiratory failure & ventilation

Epithelial injury and inflammatory phenotypes for personalized ventilation in acute respiratory distress syndrome (ARDS): Secondary analysis of the LIVE trial

ChestPublished Secondary analysis of the LIVE randomised trial

Authors' conclusion

In ARDS, epithelial injury assessed by plasma sRAGE may identify heterogeneity of treatment effect with lung recruitment, whereas inflammatory phenotypes remained prognostic for mortality.

Study context

Population
Patients with focal or non-focal ARDS in the LIVE trial with plasma sRAGE measurements; baseline sRAGE dichotomised at 2,440 pg/mL (high vs low)with plasma sRAGE
Participants
259 patients
Comparison
Lung recruitment vs Low PEEP
Primary endpoint
90-day mortality
Follow-up
90 days
Methodological detailsinverse probability weighting, weighted Cox models, joint models
  • Inverse probability weighting
  • Weighted Cox models
  • Joint models

Primary result

As reported in the abstract

90-day mortality by subgroup
Lung recruitment vs Low PEEPHazard ratio (95% CI)P value
high-sRAGE
0.41(0.18–0.93)
P = 0.033
low-sRAGE
3.27(1.06–10.1)
P = 0.039
Treatment effect varied by baseline sRAGE
P for interaction = 0.006
Treatment effect did not vary by inflammatory phenotype
P for interaction = 0.56

Secondary outcomes

sRAGE trajectory until day 6

Lung recruitment: steeper sRAGE decline in high baseline sRAGE
P for interaction < 0.001
Lung recruitment: slower sRAGE decline in low baseline sRAGE
P for interaction = 0.038

90-day mortality, hyperinflammatory vs hypoinflammatory phenotype

Hyperinflammatory phenotype associated with 90-day mortality (57% vs 26%)
P < 0.001

Correlation of high plasma sRAGE with non-focal ARDS

Moderate correlation r=0.26
P < 0.001
  • Inflammatory phenotype not correlated

Original publication

Epithelial injury and inflammatory phenotypes for personalized ventilation in ARDS: Secondary analysis of the LIVE trial. Chest. Published 23 September 2026. doi:10.1016/j.chest.2026.08.054

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.